EGFR inhibitors (Shaanxi University of Chinese Medicine/Northwest University/Xijing Hospital)

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameEGFR inhibitors (Shaanxi University of Chinese Medicine/Northwest University/Xijing Hospital)
Drug Alias Namecordycepin derivatives (Shaanxi University of Chinese Medicine/Northwest University/Xijing Hospital)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShaanxi University Of Chinese Medicine
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital of Air Force Medical UniversityNorthwest UniversityShaanxi University Of Chinese Medicine
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A